News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
531,665 Results
Type
Article (35379)
Company Profile (68)
Press Release (496218)
Section
Business (149971)
Career Advice (1613)
Deals (29478)
Drug Delivery (99)
Drug Development (68534)
Employer Resources (112)
FDA (13574)
Job Trends (11503)
News (267396)
Policy (29128)
Tag
2024 BioCapital Digital (2)
2024 BioForest Digital (1)
2024 BioMidwest Digital (1)
2024 Bio NC Digital (1)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (5)
2024 Biotech Beach Digital (1)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (1)
2024 Genetown Standard (7)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (1)
2024 Pharm Country Standard (2)
2025 Lone Star Bio Digital (1)
2026 BioCapital Standard (1)
2026 Pharm Country Premier (1)
Academia (2126)
Accelerated approval (1)
Adcomms (24)
Allergies (68)
Alliances (45749)
ALS (66)
Alzheimer's disease (1251)
Antibody-drug conjugate (ADC) (88)
Approvals (13554)
Artificial intelligence (176)
Autoimmune disease (10)
Automation (9)
Bankruptcy (270)
Best Places to Work (9842)
BIOSECURE Act (15)
Biosimilars (86)
Biotechnology (51)
Bladder cancer (48)
Brain cancer (24)
Breast cancer (204)
Cancer (1582)
Cardiovascular disease (115)
Career advice (1347)
Career pathing (22)
CAR-T (116)
Cell therapy (331)
Cervical cancer (14)
Clinical research (55216)
Collaboration (652)
Compensation (338)
Complete response letters (20)
COVID-19 (2612)
CRISPR (31)
C-suite (108)
Cystic fibrosis (74)
Data (1509)
Decentralized trials (1)
Denatured (10)
Depression (36)
Diabetes (212)
Diagnostics (5157)
Digital health (15)
Diversity (4)
Diversity, equity & inclusion (35)
Drug discovery (87)
Drug pricing (101)
Drug shortages (29)
Duchenne muscular dystrophy (60)
Earnings (65126)
Editorial (30)
Employer branding (15)
Employer resources (101)
Events (83819)
Executive appointments (354)
FDA (14414)
Featured Employer (20)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (5)
Funding (472)
Gene editing (75)
Generative AI (16)
Gene therapy (227)
GLP-1 (687)
Government (4439)
Grass and pollen (4)
Guidances (42)
Healthcare (15794)
Huntington's disease (20)
IgA nephropathy (18)
Immunology and inflammation (74)
Indications (22)
Infectious disease (2735)
Inflammatory bowel disease (106)
Inflation Reduction Act (7)
Influenza (44)
Intellectual property (69)
Interviews (280)
IPO (14442)
IRA (40)
Job creations (2083)
Job search strategy (1162)
Kidney cancer (8)
Labor market (11)
Layoffs (305)
Leadership (9)
Legal (7460)
Liver cancer (57)
Lung cancer (223)
Lymphoma (104)
Machine learning (2)
Management (33)
Manufacturing (208)
MASH (49)
Medical device (10441)
Medtech (10444)
Mergers & acquisitions (15411)
Metabolic disorders (572)
Multiple sclerosis (53)
NASH (21)
Neurodegenerative disease (65)
Neuropsychiatric disorders (20)
Neuroscience (1636)
NextGen: Class of 2025 (4931)
Non-profit (3374)
Northern California (1898)
Now hiring (15)
Obesity (325)
Opinion (200)
Ovarian cancer (50)
Pain (61)
Pancreatic cancer (64)
Parkinson's disease (105)
Partnered (11)
Patents (159)
Patient recruitment (68)
Peanut (40)
People (31711)
Pharmaceutical (22)
Pharmacy benefit managers (15)
Phase I (16763)
Phase II (24193)
Phase III (18958)
Pipeline (722)
Podcasts (36)
Policy (94)
Postmarket research (2121)
Preclinical (6880)
Press Release (38)
Prostate cancer (73)
Psychedelics (30)
Radiopharmaceuticals (224)
Rare diseases (291)
Real estate (3343)
Recruiting (48)
Regulatory (19000)
Reports (24)
Research institute (1857)
Resumes & cover letters (244)
Rett syndrome (2)
RNA editing (1)
RSV (41)
Schizophrenia (59)
Series A (84)
Series B (46)
Service/supplier (4)
Sickle cell disease (44)
Southern California (1595)
Special edition (5)
Sponsored (23)
Startups (2273)
State (1)
Stomach cancer (11)
Supply chain (49)
The Weekly (26)
United States (16173)
Vaccines (677)
Venture capitalists (21)
Webinars (8)
Weight loss (244)
Women's health (18)
Worklife (11)
Date
Today (141)
Last 7 days (683)
Last 30 days (2638)
Last 365 days (29432)
2025 (4969)
2024 (30236)
2023 (34685)
2022 (44374)
2021 (48070)
2020 (46002)
2019 (37633)
2018 (28539)
2017 (26524)
2016 (24982)
2015 (29512)
2014 (21768)
2013 (17425)
2012 (18766)
2011 (19663)
2010 (17667)
Location
Africa (657)
Alabama (44)
Alaska (6)
Arizona (132)
Arkansas (9)
Asia (31219)
Australia (5530)
California (4214)
Canada (1484)
China (341)
Colorado (190)
Connecticut (206)
Delaware (98)
Europe (76115)
Florida (643)
Georgia (157)
Hawaii (1)
Idaho (36)
Illinois (344)
India (18)
Indiana (231)
Iowa (4)
Japan (113)
Kansas (71)
Kentucky (18)
Louisiana (7)
Maine (65)
Maryland (695)
Massachusetts (3219)
Michigan (144)
Minnesota (244)
Mississippi (1)
Missouri (61)
Montana (24)
Nebraska (14)
Nevada (44)
New Hampshire (48)
New Jersey (1224)
New Mexico (19)
New York (1190)
North Carolina (714)
North Dakota (5)
Northern California (1898)
Ohio (133)
Oklahoma (8)
Oregon (17)
Pennsylvania (997)
Puerto Rico (4)
Rhode Island (14)
South America (925)
South Carolina (9)
South Dakota (1)
Southern California (1595)
Tennessee (54)
Texas (598)
Utah (128)
Virginia (90)
Washington D.C. (38)
Washington State (410)
West Virginia (2)
Wisconsin (33)
531,665 Results for "ava ag".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
CORRECTING and REPLACING Access Vascular Highlights New Midline Catheter Data at AVA 2024
Data Presented at the AVA Annual Scientific Meeting Shows Significantly Lower Complication and Failure Rates with Access Vascular’s HydroMID® Midline Catheter
October 2, 2024
·
2 min read
Press Releases
Avacta Announces Positive New Data from the AVA6000 Phase 1 trial Demonstrating Clinically Meaningful Tumor Shrinkage in Patients with Salivary Gland Cancers
January 16, 2025
·
6 min read
Press Releases
Access Vascular Highlights New Midline Catheter Data at AVA 2024
October 1, 2024
·
2 min read
Press Releases
CORRECTING and REPLACING Access Vascular Highlights New Midline Catheter Data at AVA 2024
October 2, 2024
·
3 min read
Press Releases
Palforzia® Oral Immunotherapy for the Treatment of Peanut Allergy Now Available in the U.S. for Pediatric Ages 1 Through 3 Years
March 3, 2025
·
4 min read
Drug Development
Updated Results from Single-Agent Phase 1 Clinical Trial of Peptide Drug Conjugate, AVA6000 to be Presented in a Poster at the American Association of Cancer Research (AACR) Annual Meeting on April 9, 2024
Avacta Group plc announces updated clinical data from the First-in-Human Phase 1 trial of the peptide drug conjugate, AVA6000 will be presented at the 2024 American Association for Cancer Research Annual Meeting, taking place in San Diego, California from 5-10 April 2024.
March 5, 2024
·
3 min read
Press Releases
Avacta to present updated clinical data on AVA6000 at the European Society for Medical Oncology (ESMO) Congress
September 9, 2024
·
2 min read
Biotech Bay
23andMe Launches Month-Long Initiative to Amplify ARRAY’s “Seat16” Program for Acclaimed Film ORIGIN by Ava DuVernay
23andMe Holding Co., a leading genetic health and biopharmaceutical company, announced a month-long initiative to amplify Ava DuVernay’s new film ORIGIN and the film’s groundbreaking Seat16 program.
January 30, 2024
·
1 min read
Policy
AVEROA Submits Marketing Authorisation Application to the European Medicines Agency Seeking Approval of AVA1014 for Treating Complications Associated with Chronic Kidney Disease
Averoa announces the submission of a marketing authorisation application to the European Medicines Agency for Ferric Citrate Coordination Complex, an oral iron-based compound for patients suffering from Chronic Kidney disease.
April 23, 2024
·
3 min read
Deals
Ad hoc: Novartis BidCo Germany AG Intends to Implement a Merger Squeeze-out of MorphoSys AG’s Minority Shareholders
MorphoSys AG announces that Novartis BidCo Germany AG informed the MorphoSys AG Management Board of its intention to merge MorphoSys AG as transferring company into Novartis BidCo Germany AG.
June 20, 2024
·
4 min read
1 of 53,167
Next
